These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 2811598)
21. Dopaminergic neurons in explants of substantia nigra in culture. Coyle JT; Jacobowitz D; Klein D; Axelrod J J Neurobiol; 1973; 4(5):461-70. PubMed ID: 4147763 [No Abstract] [Full Text] [Related]
22. Effects of a short period of vitamin E-deficient diet in the turnover of different neurotransmitters in substantia nigra and striatum of the rat. Castaño A; Herrera AJ; Cano J; Machado A Neuroscience; 1993 Mar; 53(1):179-85. PubMed ID: 7682297 [TBL] [Abstract][Full Text] [Related]
23. Anxiolytic property of estrogen related to the changes of the monoamine levels in various brain regions of ovariectomized rats. Pandaranandaka J; Poonyachoti S; Kalandakanond-Thongsong S Physiol Behav; 2006 Apr; 87(4):828-35. PubMed ID: 16545402 [TBL] [Abstract][Full Text] [Related]
24. Evidence for dopamine release and metabolism beyond the control of nerve impulses and dopamine receptors in rat substantia nigra. Nissbrandt H; Pileblad E; Carlsson A J Pharm Pharmacol; 1985 Dec; 37(12):884-9. PubMed ID: 2868096 [TBL] [Abstract][Full Text] [Related]
25. Microdialysis study of the effects of the antiparkinsonian drug budipine on L-DOPA-induced release of dopamine and 5-hydroxytryptamine by rat substantia nigra and corpus striatum. Biggs CS; Starr MS Synapse; 1999 Oct; 34(1):36-46. PubMed ID: 10459170 [TBL] [Abstract][Full Text] [Related]
26. Effects of acute GR38032F (odansetron), a 5-HT3 receptor antagonist, on dopamine and serotonin metabolism in mesolimbic and nigrostriatal dopaminergic neurons. Koulu M; Sjöholm B; Lappalainen J; Virtanen R Eur J Pharmacol; 1989 Oct; 169(2-3):321-4. PubMed ID: 2530097 [TBL] [Abstract][Full Text] [Related]
27. Influence of monoamine oxidase inhibition on the release of 3H-dopamine elicited by potassium and by amphetamine from the rat substantia nigra and corpus striatum. Arbilla S; Langer SZ Naunyn Schmiedebergs Arch Pharmacol; 1980 Feb; 311(1):45-52. PubMed ID: 7366741 [No Abstract] [Full Text] [Related]
28. Effects of neonatal bilateral eye enucleation on postnatal development of the monoamines in posterior thalamus of the rat. Vizuete ML; Santiago M; Herrera AJ; Venero JL; Machado A; Cano J J Neural Transm Gen Sect; 1991; 85(3):231-42. PubMed ID: 1681825 [TBL] [Abstract][Full Text] [Related]
29. Inhibition of monoamine oxidase within monoaminergic neurons in the rat brain by (E)-beta-fluoromethylene-m-tyrosine (MDL 72394). Fagervall I; Ross SB J Neurochem; 1989 Feb; 52(2):467-71. PubMed ID: 2521360 [TBL] [Abstract][Full Text] [Related]
30. Nigrostriatal monoamine oxidase A and B in aging squirrel monkeys and C57BL/6 mice. Irwin I; Delanney L; Chan P; Sandy MS; Di Monte DA; Langston JW Neurobiol Aging; 1997; 18(2):235-41. PubMed ID: 9258902 [TBL] [Abstract][Full Text] [Related]
31. Participation of type A monoamine oxidase in the activated deamination of brain monoamines shortly after reperfusion in rats. Kumagae Y; Matsui Y; Iwata N Jpn J Pharmacol; 1990 Dec; 54(4):407-13. PubMed ID: 2087001 [TBL] [Abstract][Full Text] [Related]
32. Synthesis and release of dopamine in rat brain: comparison between substantia nigra pars compacts, pars reticulata, and striatum. Nissbrandt H; Sundström E; Jonsson G; Hjorth S; Carlsson A J Neurochem; 1989 Apr; 52(4):1170-82. PubMed ID: 2564423 [TBL] [Abstract][Full Text] [Related]
33. Monoamine levels and monoamine oxidase activity in different regions of rat brain as a function of age. Bhaskaran D; Radha E Mech Ageing Dev; 1983 Oct; 23(2):151-60. PubMed ID: 6140331 [TBL] [Abstract][Full Text] [Related]
34. [Effects of acrylonitrile in drinking water on monoamine neurotransmitters and its metabolites in male rat brains]. Lu RZ; Chen ZQ; Jin FS Zhonghua Yu Fang Yi Xue Za Zhi; 2005 Mar; 39(2):122-5. PubMed ID: 15842835 [TBL] [Abstract][Full Text] [Related]
35. Modulation of methylenedioxymethamphetamine-induced striatal dopamine release by the interaction between serotonin and gamma-aminobutyric acid in the substantia nigra. Yamamoto BK; Nash JF; Gudelsky GA J Pharmacol Exp Ther; 1995 Jun; 273(3):1063-70. PubMed ID: 7791076 [TBL] [Abstract][Full Text] [Related]
36. Neurochemical characterization of the release and uptake of dopamine in ventral tegmental area and serotonin in substantia nigra of the mouse. John CE; Budygin EA; Mateo Y; Jones SR J Neurochem; 2006 Jan; 96(1):267-82. PubMed ID: 16300629 [TBL] [Abstract][Full Text] [Related]
37. [Changes in brain monoamine neurotransmitter in iron deficiency nonanemic rats]. Hu R; Wei M; Ding X Zhonghua Yu Fang Yi Xue Za Zhi; 1996 Nov; 30(6):351-3. PubMed ID: 9388911 [TBL] [Abstract][Full Text] [Related]
38. Effect of nigral and raphé lesions on the catechol-O-methyl transferase and monoamine oxidase activities in the rat striatum. Marsden CA; Broch OJ; Guldberg HC Eur J Pharmacol; 1972 Jul; 19(1):35-42. PubMed ID: 4558780 [No Abstract] [Full Text] [Related]
39. Immunohistochemical detection of L-DOPA-derived dopamine within serotonergic fibers in the striatum and the substantia nigra pars reticulata in Parkinsonian model rats. Yamada H; Aimi Y; Nagatsu I; Taki K; Kudo M; Arai R Neurosci Res; 2007 Sep; 59(1):1-7. PubMed ID: 17586078 [TBL] [Abstract][Full Text] [Related]
40. Monoamine oxidase-inhibition and MPTP-induced neurotoxicity in the non-human primate: comparison of rasagiline (TVP 1012) with selegiline. Kupsch A; Sautter J; Götz ME; Breithaupt W; Schwarz J; Youdim MB; Riederer P; Gerlach M; Oertel WH J Neural Transm (Vienna); 2001; 108(8-9):985-1009. PubMed ID: 11716151 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]